VIGL Company Profile and Key Details

Q: Who are the executives of VIGL?

Mr. Charles MaggsHead of FP&AKelly Neelon Ph.D.Vice President of CMC & Technical OperationsChristian Mirescu Ph.D.Vice President & Head of NeuroimmunologyMs. Jennifer Ziolkowski CPA, CPAChief Financial OfficerMr. Evan A. Thackaberry DABT, Ph.D.Senior Vice President & Head of Early Devel.Ms. Sarah CarmodyVice President of Investor Relations & Corporation CommunicationsDr. Ivana Magovcevic-Liebisch J.D., Ph.D.Pres, Chief Executive Officer & DirectorPark Guo CPAAccounting Mang.Weeteck Yeo Ph.D.Senior Vice President of Strategic OperationsMr. Christopher Verni J.D.Gen. Counsel & Corporation Sec.Dr. David Gray Ph.D.Chief Scientific OfficerApril Effort M.B.A., M.S.Vice President & Head of Corporation Devel.

NASDAQ : VIGL

Vigil Neuroscience

$8.05

At Close 4:00 PM

Not Actively Trading

62.36

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Vigil Neuroscience, Inc. (VIGL) stock remained unchanged at $8.05 a share on NASDAQ. The stock opened at $8.05, fluctuating between $8.05 to $8.05 during the session.

Stock Snapshot

8.05

Prev. Close

375.71M

Market Cap

8.05

Day Low

-3.8333333333333335

P/E Ratio

-2.1

EPS (TTM)

-1.83

Cash Flow per Share

8.05

Open

46.67M

Number of Shares

8.05

Day High

67.02%

Free Float in %

2.99

Book Value

5.51M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 05, 2025	8.05	8.05	8.05	8.05	0
Aug 04, 2025	8.05	8.10	8.04	8.05	5.51M
Aug 01, 2025	8.05	8.06	8.02	8.05	2.49M
Jul 31, 2025	8.04	8.06	8.03	8.05	1.57M
Jul 30, 2025	8.05	8.06	8.04	8.05	837.52K
Jul 29, 2025	8.06	8.07	8.05	8.06	565.62K
Jul 28, 2025	8.05	8.06	8.05	8.06	195.9K
Jul 25, 2025	8.05	8.07	8.05	8.05	466K
Jul 24, 2025	8.07	8.08	8.05	8.05	430.4K
Jul 23, 2025	8.07	8.09	8.07	8.07	303.96K
Jul 22, 2025	8.07	8.08	8.06	8.06	205.2K
Jul 21, 2025	8.06	8.08	8.06	8.08	338.03K
Jul 18, 2025	8.08	8.09	8.07	8.07	3.94M
Jul 17, 2025	8.10	8.10	8.07	8.08	1.62M
Jul 16, 2025	8.06	8.08	8.06	8.07	325.34K
Jul 15, 2025	8.07	8.09	8.06	8.06	383.84K
Jul 14, 2025	8.04	8.07	8.03	8.07	490.26K
Jul 11, 2025	8.04	8.06	8.04	8.05	315.2K
Jul 10, 2025	8.01	8.04	8.00	8.04	566.28K
Jul 09, 2025	8.05	8.05	8.00	8.01	458.65K

Contact Details

Watertown, MA 02142

United States

https://www.vigilneuro.com 857 254 4445

About Company

Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.

Stock Peers

ARGX

27.59+3.52%

argenx SE$811.09 REGN

7.79+1.11%

Regeneron Pharmaceuticals, Inc.$709.21 UTHR

10.82+1.90%

United Therapeutics Corporation$581.22 MDGL

4.94002+0.96%

Madrigal Pharmaceuticals, Inc.$518.66 VRTX

5.93+1.40%

Vertex Pharmaceuticals Incorporated$429.85 PRAX

13.41+4.14%

Praxis Precision Medicines, Inc.$337.61 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.815+0.61%

Alnylam Pharmaceuticals, Inc.$297.93 KRYS

20.91+7.86%

Krystal Biotech, Inc.$286.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Vigil Neuroscience, Inc. (VIGL) stock price?

Vigil Neuroscience, Inc. (NASDAQ: VIGL) stock price is $8.05 in the last trading session. During the trading session, VIGL stock reached the peak price of $8.05 while $8.05 was the lowest point it dropped to. The percentage change in VIGL stock occurred in the recent session was 0% while the dollar amount for the price change in VIGL stock was $0.00.

VIGL's industry and sector of operation?

The NASDAQ listed VIGL is part of Biotechnology industry that operates in the broader Healthcare sector. Vigil Neuroscience, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VIGL?

Mr. Charles Maggs
Head of FP&A
Kelly Neelon Ph.D.
Vice President of CMC & Technical Operations
Christian Mirescu Ph.D.
Vice President & Head of Neuroimmunology
Ms. Jennifer Ziolkowski CPA, CPA
Chief Financial Officer
Mr. Evan A. Thackaberry DABT, Ph.D.
Senior Vice President & Head of Early Devel.
Ms. Sarah Carmody
Vice President of Investor Relations & Corporation Communications
Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Pres, Chief Executive Officer & Director
Park Guo CPA
Accounting Mang.
Weeteck Yeo Ph.D.
Senior Vice President of Strategic Operations
Mr. Christopher Verni J.D.
Gen. Counsel & Corporation Sec.
Dr. David Gray Ph.D.
Chief Scientific Officer
April Effort M.B.A., M.S.
Vice President & Head of Corporation Devel.

How VIGL did perform over past 52-week?

VIGL's closing price is 513.57% higher than its 52-week low of $1.31 where as its distance from 52-week high of $8.10 is -0.62%.

How many employees does VIGL have?

Number of VIGL employees currently stands at 69.

Link for VIGL official website?

Official Website of VIGL is: https://www.vigilneuro.com

How do I contact VIGL?

VIGL could be contacted at phone 857 254 4445 and can also be accessed through its website. VIGL operates from 1 Broadway, Watertown, MA 02142, United States.

How many shares of VIGL are traded daily?

VIGL stock volume for the day was 5.51M shares. The average number of VIGL shares traded daily for last 3 months was 1.65M.

What is the market cap of VIGL currently?

The market value of VIGL currently stands at $375.71M with its latest stock price at $8.05 and 46.67M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	69
Beta	3.34
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	69
Beta	3.34
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

VIGL Company Profile and Key Details

Vigil Neuroscience

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways